TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008Vol.31 No.9
TCL Archive NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines. September 19, 2008Vol.34 No.34
